EUVIMEDEUVIMED entdecken
Crossref

Structure-Guided Optimization of p62-Directed AUTOTACs for Efficient EGFR/VEGFR2 Degradation and Antitumor Efficacy

Defa Wu iD, Yongya Wu, Min Zhao, Yang Li, Haolin Tang, Wenqing Chen, Maolin Duan, Guotai Feng, Lang Zheng, Shuo Wang, Yiwen Zhang, Jie Liu und 2 weitere

Journal of Medicinal Chemistry · 13.08.2026 · 69 (15) · 18226-18254

DOI: 10.1021/acs.jmedchem.6c00670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 21.07.2026. Verfasst von Defa Wu und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu610041, China. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents, Sequestosome-1 Protein, Protein Kinase Inhibitors. Die Arbeit nennt 54 Literaturangaben. Gefördert von: State Key Laboratory of Natural and Biomimetic Drugs, National Natural Science Foundation of China, Youth Fund of Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Receptor tyrosine kinases (RTKs) are core cancer therapeutic targets, yet their integral membrane localization hinders efficient degradation by traditional ubiquitin–proteasome system (UPS)-based targeted protein degradation (TPD) strategies. Herein, we describe the structure-guided development of p62/SQSTM1-directed autophagy-targeting chimera (AUTOTAC) degraders targeting RTKs. Medicinal chemistry optimization yielded two potent AUTOTACs, 6d and 11bg, which selectively degrade EGFR and VEGFR2, respectively. Mechanistic studies confirmed that these degraders act via p62 recruitment and autophagy–lysosome pathway activation in a UPS-independent manner. 6d and 11bg exhibited robust antiproliferative, proapoptotic, and antimigratory effects in vitro, and 6d further demonstrated significant in vivo antitumor efficacy with good tolerability in xenograft models. This study validates AUTOTAC technology for RTK degradation, offering a new approach to address TKI resistance and broaden the TPD landscape.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsSequestosome-1 ProteinProtein Kinase InhibitorsHumansErbB ReceptorsAnimalsMiceProteolysisProteolysis Targeting ChimeraAutophagyCell Line, TumorStructure-Activity RelationshipCell ProliferationMice, NudeXenograft Model Antitumor AssaysApoptosis

Substanzen

ErbB ReceptorsVascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsSequestosome-1 ProteinProteolysis Targeting ChimeraEGFR protein, humanSQSTM1 protein, humanKDR protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu610041, China.
  • Institute of Materia Medica, Key Laboratory of Structure-Specific Small Molecule Drugs at Chengdu Medical College of Sichuan Province, School of Pharmacy, Chengdu Medical College, Chengdu610500, China.
  • West China Medical Publishers, West China Hospital, Sichuan University, Chengdu610041, China.

ORCID-Profile: Defa Wu, Liang Ouyang, Qiu Sun

Förderung

  • State Key Laboratory of Natural and Biomimetic Drugs
  • National Natural Science Foundation of China
  • Youth Fund of Natural Science Foundation of Sichuan Province
  • Support Program of Science & Technology Department of Sichuan Provincial

Zitieren

APA

Wu, D., Wu, Y., Zhao, M., Li, Y., Tang, H., Chen, W., Duan, M., Feng, G., Zheng, L., Wang, S., Zhang, Y., Liu, J., Ouyang, L., & Sun, Q. (2026). Structure-Guided Optimization of p62-Directed AUTOTACs for Efficient EGFR/VEGFR2 Degradation and Antitumor Efficacy. Journal of Medicinal Chemistry, 69(15), 18226-18254. https://doi.org/10.1021/acs.jmedchem.6c00670

Vancouver

Wu D, Wu Y, Zhao M, Li Y, Tang H, Chen W, et al. Structure-Guided Optimization of p62-Directed AUTOTACs for Efficient EGFR/VEGFR2 Degradation and Antitumor Efficacy. Journal of Medicinal Chemistry. 2026;69(15):18226-18254. doi:10.1021/acs.jmedchem.6c00670

BibTeX
@article{Wu2026,
  author = {Wu, Defa and Wu, Yongya and Zhao, Min and Li, Yang and Tang, Haolin and Chen, Wenqing and Duan, Maolin and Feng, Guotai and Zheng, Lang and Wang, Shuo and Zhang, Yiwen and Liu, Jie and Ouyang, Liang and Sun, Qiu},
  title = {Structure-Guided Optimization of p62-Directed AUTOTACs for Efficient EGFR/VEGFR2 Degradation and Antitumor Efficacy},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {15},
  pages = {18226--18254},
  doi = {10.1021/acs.jmedchem.6c00670}
}
Kostenlos starten →